Paushak FY26 Audited Results Ad Published; Dividend of Rs. 2.50 Recommended
Paushak Limited announced its audited FY26 results on 5 May 2026, reporting a revenue of Rs. 21,860 lacs and a net profit of Rs. 3,933 lacs. Q4 performance showed growth with net profit increasing to Rs. 1,251 lacs. The company published these results in newspapers on 6 May 2026 and recommended a dividend of Rs. 2.50 per share.
*this image is generated using AI for illustrative purposes only.
Paushak Limited announced its audited financial results for the quarter and financial year ended 31st March, 2026, following a Board of Directors meeting held on 5th May, 2026. The statutory auditors, M/s. CNK & Associates LLP, Chartered Accountants, issued an unmodified audit opinion on the financial results, in compliance with Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company operates solely in the Speciality Chemicals segment, which constitutes the only reportable business segment. Subsequently, on 6th May, 2026, Paushak filed an intimation under Regulation 30 and Regulation 47 of the SEBI Listing Regulations, enclosing copies of newspaper advertisements related to the audited financial results published in The Indian Express (English) and Financial Express (Gujarati). The advertisements provided a QR Code and weblink to access the complete financial results on the company's website.
Financial Performance Overview
For the full financial year ended 31st March, 2026, Paushak reported revenue from operations of Rs. 21,860 lacs, compared to Rs. 21,095 lacs in the previous year. Total income for FY26 stood at Rs. 23,071 lacs versus Rs. 22,519 lacs in FY25. Profit after tax for the year came in at Rs. 3,933 lacs, declining from Rs. 4,938 lacs in FY25. Total comprehensive income for FY26 was Rs. 3,180 lacs, compared to Rs. 6,768 lacs in the prior year. Basic and diluted earnings per share for FY26 stood at Rs. 15.95, against Rs. 20.03 in FY25, with prior period figures restated to reflect the sub-division of shares and allotment of bonus shares in line with Ind AS 33. On a quarterly basis, Q4 net profit rose to Rs. 1,251 lacs from Rs. 960 lacs in Q4 FY25, while Q4 revenue from operations grew to Rs. 5,514 lacs from Rs. 5,236 lacs in the same period last year.
The following table summarises the key financial metrics for the year and the most recent quarter:
| Metric: | Q4 FY26 (31.03.2026) | Q3 FY26 (31.12.2025) | Q4 FY25 (31.03.2025) | FY26 (31.03.2026) | FY25 (31.03.2025) |
|---|---|---|---|---|---|
| Revenue from Operations (Rs. lacs): | 5,514 | 4,880 | 5,236 | 21,860 | 21,095 |
| Other Income (Rs. lacs): | 821 | 97 | 11 | 1,211 | 1,424 |
| Total Income (Rs. lacs): | 6,335 | 4,977 | 5,247 | 23,071 | 22,519 |
| Total Expenses (Rs. lacs): | 4,733 | 4,235 | 4,024 | 18,030 | 16,641 |
| Profit Before Tax (Rs. lacs): | 1,602 | 742 | 1,223 | 5,041 | 5,877 |
| Profit After Tax (Rs. lacs): | 1,251 | 617 | 960 | 3,933 | 4,938 |
| Total Comprehensive Income (Rs. lacs): | 478 | 606 | 1,747 | 3,180 | 6,768 |
| Basic & Diluted EPS (Rs.): | 5.07 | 2.50 | 3.90 | 15.95 | 20.03 |
EBITDA Performance
On an operational efficiency basis, Paushak's Q4 EBITDA improved on a year-on-year basis. The following table presents the key EBITDA metrics for Q4:
| Metric: | Q4 FY26 | Q4 FY25 |
|---|---|---|
| EBITDA (Rupees): | 167M | 159M |
| EBITDA Margin (%): | 30.34% | 30.33% |
Dividend Recommendation
The Board of Directors recommended a dividend of Rs. 2.50 per equity share (50%) on shares with a face value of Rs. 5 each for the financial year ended 31st March, 2026, subject to approval by shareholders at the ensuing Annual General Meeting. This compares to a dividend of Rs. 20 per share (200%) declared for the previous year. Paid-up equity share capital as at 31st March, 2026 stood at Rs. 1,233 lacs, with other equity excluding revaluation reserves at Rs. 38,363 lacs.
Historical Stock Returns for Paushak
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.06% | +10.61% | +20.97% | -12.51% | -12.51% | -12.51% |
How will the significant capital expenditure of Rs. 8,809 lacs and the commissioning of new plant assets reflected in the PP&E jump impact Paushak's revenue capacity and margins in FY27?
Given the sharp dividend cut from Rs. 20 to Rs. 2.50 per share alongside rising borrowings, what is management's capital allocation strategy and timeline for deleveraging as new capacities ramp up?
With material costs surging nearly 32% year-on-year, how exposed is Paushak to raw material price volatility, and what hedging or backward integration strategies is the company considering?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
